LAB – standard biotools inc. (US:NASDAQ)

News

Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry [Yahoo! Finance]
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Standard BioTools (NASDAQ:LAB) had its price target lowered by analysts at TD Cowen from $1.55 to $1.35. They now have a "hold" rating on the stock.
Standard BioTools Reports Third Quarter 2025 Financial Results
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com